Senataxin cooperates with the breast and ovarian cancer BRCA1 protein in the removal of R-loop-driven DNA damage at transcribed genes [6] and was found down-regulated in a range of cancer types, including ovarian cancer, suggesting a tumor suppressor activity [1]. This evidence concerns the gene BRCA1 and ovarian cancer.